🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-center, single-arm, open-label, self-controlled, phase I c...
Status
Completed
Location
West China Second University Hospital Ethics Committee
Start Date
2020-09-03
Trial ID
NCT05088174
Treatments Being Tested
This three-arm study will evaluate the efficacy and safety of various dosin...
Status
Completed
Location
Multiple Locations
Start Date
2004-06
Trial ID
NCT00087581
Treatments Being Tested
The study will evaluate the efficacy of cyclosporine at 2, 5 mg/kg/day bid ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2006-05
Trial ID
NCT00438360
Treatments Being Tested
The purpose of this study was to evaluate whether delayed (i.e. 28 ± 4 days...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-11
Trial ID
NCT01410448
Treatments Being Tested
The purpose of this large multicenter, randomized, double-blinded, controll...
Status
Unknown
Location
Peking University People's Hospital
Start Date
2015-03
Trial ID
NCT02370550
Treatments Being Tested
This is a single-center, non-randomized, open-label, self-controlled, Phase...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-11
Trial ID
NCT07565441
The aims of this study are to extensively study the levels of CD25-Receptor...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-03
Trial ID
NCT01596062
Treatments Being Tested
A drug-drug interaction study between eltrombopag and cyclosporine is being...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-05
Trial ID
NCT02281370
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of eltrom...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-05-11
Trial ID
NCT02998645
Treatments Being Tested
This is a prospective, multicenter, randomized, open-label, parallel contro...
Status
Recruiting
Location
Chinese PLA general hospital
Start Date
2023-05-09
Trial ID
NCT05839314